Compare Stocks → Beta testers blew this thing up (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare ShareLink copied to clipboard. CVE:EMHNYSE:PYX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shsPYXSchroders$2.91$0.00$0.00▼$0.00$72.75MN/AN/AN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%PYXSchroders0.00%0.00%0.00%0.00%0.00%Beta testers blew this thing up (Ad)This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it)Click Here To Read More About This Game Changing AI ToolMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/APYXSchrodersN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMHEmerald Health TherapeuticsN/AN/AN/AN/APYXSchrodersN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64PYXSchroders$2.03B0.04N/AN/A$5.87 per share0.50Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/APYXSchroders$2.66MN/A0.00∞N/A0.13%1.76%0.15%9/5/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/APYXSchrodersN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMHEmerald Health Therapeutics35.452.972.61PYXSchroders3.391.450.42OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMHEmerald Health TherapeuticsN/APYXSchrodersN/AInsider OwnershipCompanyInsider OwnershipEMHEmerald Health TherapeuticsN/APYXSchroders10.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionablePYXSchroders3,00025.00 million22.50 millionOptionableHE1, PYX, EMH, and CUSN HeadlinesRecent News About These CompaniesJune 12, 2024 | prnewswire.co.ukSchroders Bolsters Regulatory Reporting Tech with Implementation of Broadridge's Consumer Duty Solution for Distributor FeedbackFebruary 14, 2024 | prnewswire.comPyxus International, Inc. Reports Strong Third Quarter and Year-to-Date Fiscal 2024 ResultsOctober 13, 2023 | smith.eduPoetry ConcentrationOctober 11, 2023 | ft.comFT Business Book of the Year 2023 — the shortlistOctober 11, 2023 | health.usnews.comTerry SchroderSeptember 20, 2023 | msn.comLouisiana governor's field shrinks as Richard Nelson bows out, endorses Jeff LandryAugust 13, 2023 | proactiveinvestors.co.ukPYX Resources to export ilmenite and rutile after Indonesia law changeJuly 31, 2023 | sportingnews.comDennis Schroder-Maxi Kleber beef, explained: How drama impacted Germany's roster for FIBA Basketball World CupJune 11, 2023 | politico.euGerman court: Former Chancellor Schröder has no right to office in the BundestagApril 20, 2023 | dailygazette.comLongtime Capital Region radio personality Bob Mason diesApril 12, 2023 | markets.businessinsider.comCash is king for millennials with the group shunning other assets like stocks and bonds, survey showsMarch 11, 2023 | cbssports.comLakers' Dennis Schroder: Returning to benchFebruary 19, 2023 | dailygazette.comPYX-106 listeners won’t be waking up to ‘Wolf’ anymoreFebruary 10, 2023 | morningstar.comHartford Schroders Emerging Mkts Eq YJanuary 4, 2023 | hl.co.ukPYX Resources Ltd (PYX) NPV (DI)October 14, 2022 | cbssports.comDennis Schroder says he has 'unfinished business' with Lakers after denying team ever offered him extensionOctober 12, 2022 | latimes.comDennis Schroder makes Lakers practice debut and sets record straight on contractSeptember 21, 2022 | lse.co.ukPyx Resources Share ChatAugust 31, 2022 | uk.investing.comDisty Technologies SA (DYT)May 17, 2022 | lse.co.ukWednesday preview: UK CPÎ, Burberry in focusCompany DescriptionsEmerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.SchrodersNYSE:PYXPyxus International, Inc. operates as an agricultural company. It delivers value-added products and services in leaf tobacco, e-liquids, industrial hemp and legal cannabis industries. Pyxus International Inc., formerly known as Alliance One International Inc., is headquartered in Morrisville, North Carolina. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
